We provide you with 20 years of free, institutional-grade data for NVAX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of NVAX. Explore the full financial landscape of NVAX stock.
| Reported Date | Ticker | Type | |
|---|---|---|---|
| 2026-05-06 | NVAX | 10-Q | Url |
| 2026-02-26 | NVAX | 10-K | Url |
| 2025-11-06 | NVAX | 10-Q | Url |
| 2025-08-06 | NVAX | 10-Q | Url |
| 2025-05-08 | NVAX | 10-Q | Url |
| 2025-02-27 | NVAX | 10-K | Url |
| 2024-11-12 | NVAX | 10-Q | Url |
| 2024-08-08 | NVAX | 10-Q | Url |
| 2024-05-10 | NVAX | 10-Q | Url |
| 2024-02-28 | NVAX | 10-K | Url |
| 2023-11-09 | NVAX | 10-Q | Url |
| 2023-08-08 | NVAX | 10-Q | Url |
| 2023-05-09 | NVAX | 10-Q | Url |
| 2023-02-28 | NVAX | 10-K | Url |
| 2022-11-09 | NVAX | 10-Q | Url |
| 2022-08-09 | NVAX | 10-Q | Url |
| 2022-05-10 | NVAX | 10-Q | Url |
| 2022-03-01 | NVAX | 10-K | Url |
| 2021-11-05 | NVAX | 10-Q | Url |
| 2021-08-05 | NVAX | 10-Q | Url |
| 2021-05-10 | NVAX | 10-Q | Url |
| 2021-03-01 | NVAX | 10-K | Url |
| 2020-11-10 | NVAX | 10-Q | Url |
| 2020-08-10 | NVAX | 10-Q | Url |
| 2020-05-11 | NVAX | 10-Q | Url |
| 2020-03-11 | NVAX | 10-K | Url |
| 2019-11-07 | NVAX | 10-Q | Url |
| 2019-08-07 | NVAX | 10-Q | Url |
| 2019-05-02 | NVAX | 10-Q | Url |
| 2019-03-18 | NVAX | 10-K | Url |
| 2018-11-07 | NVAX | 10-Q | Url |
| 2018-08-08 | NVAX | 10-Q | Url |
| 2018-05-09 | NVAX | 10-Q | Url |
| 2018-03-14 | NVAX | 10-K | Url |
| 2017-11-07 | NVAX | 10-Q | Url |
| 2017-08-08 | NVAX | 10-Q | Url |
| 2017-05-08 | NVAX | 10-Q | Url |
| 2017-02-27 | NVAX | 10-K | Url |
| 2016-11-09 | NVAX | 10-Q | Url |
| 2016-08-09 | NVAX | 10-Q | Url |
| 2016-05-05 | NVAX | 10-Q | Url |
| 2016-02-29 | NVAX | 10-K | Url |
| 2015-11-09 | NVAX | 10-Q | Url |
| 2015-08-10 | NVAX | 10-Q | Url |
| 2015-05-07 | NVAX | 10-Q | Url |
| 2015-02-27 | NVAX | 10-K | Url |
| 2014-11-06 | NVAX | 10-Q | Url |
| 2014-08-07 | NVAX | 10-Q | Url |
| 2014-05-08 | NVAX | 10-Q | Url |
| 2014-03-12 | NVAX | 10-K | Url |
Novavax, Inc(NASDAQ:NVAX) 
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one...
Website: http://www.novavax.com
Founded: 1987
Full Time Employees: 522
CEO: Stanley C. Erck
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about NVAX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.